Search

EHA Kick-off Grant review and selection process

1. Eligibility checkAfter the deadline has passed, we'll check your application for completion and compliance with the eligibility criteria.

Read more

Publications

Ruxolitinib for the management of myelofibrosis: Results of an international physician survey. Ellis MH, Koren-Michowitz M, Lavi N, Vannucchi AM, Mesa R, Harrison CN. Leuk Res. 2017 Oct;61:6-9. doi: 10. 1016/j. leukres. 2017. 08. 002.

Read more

Fellowships & Grants Committee

Current committee members
Jean-Pierre Bourquin, Switzerland (Chair (EHA Board))
David Kent, United Kingdom (Vice-Chair (non-Board))
Regular members
Sylvia Beà, Spain
Olivier Bernard, France
Niccolò Bolli, Italy
Tom Cupedo, The Netherlands
Michaela Fontenay, France
Julia Hauer, Germany
Antonis Kattamis, Greece
Elisa Laurenti, United Kingdom
Dimitrios Mougiakakos, Germany
César Nombela-Arrieta, Switzerland
Rebekka Schneider-Kramann, The Netherlands
Jürg Schwaller, Switzerland
Anetta…

Read more

Speaker Guidelines

On this page you can find the detailed instructions for your abstract and presentation, as referred to in the Confirmation email.

Read more

David Grimwade Award

In 2017, EHA established a new award in honor of the late David Grimwade, for his great involvement and contribution to the European Hematology Association and its scientific activities as Board Member, TRTH Co-Director and Chair of the Scientific Program…

Read more

Position of EHA on Clinical Trials

 

The challenge
In Europe, the number of clinical trials is steadily decreasing. From 2007 to 2010, their number has decreased by some 20 percent from 5,028 to 4,193.

Read more